|
|
LETTER TO THE EDITOR |
|
Year : 2018 | Volume
: 31
| Issue : 4 | Page : 1482 |
|
Quality of life in patients with irritable bowel syndrome in Qaliobeya Governorate, Egypt
Mahmood D Al-Mendalawi
Department of Paediatrics, Al-Kindy College of Medicine, University of Baghdad, Baghdad, Iraq
Date of Submission | 17-Sep-2018 |
Date of Acceptance | 08-Oct-2018 |
Date of Web Publication | 14-Feb-2019 |
Correspondence Address: Mahmood D Al-Mendalawi P.O. Box. 55302, Baghdad Post Office, 1111, Baghdad Iraq
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/mmj.mmj_288_18
How to cite this article: Al-Mendalawi MD. Quality of life in patients with irritable bowel syndrome in Qaliobeya Governorate, Egypt. Menoufia Med J 2018;31:1482 |
How to cite this URL: Al-Mendalawi MD. Quality of life in patients with irritable bowel syndrome in Qaliobeya Governorate, Egypt. Menoufia Med J [serial online] 2018 [cited 2024 Mar 29];31:1482. Available from: http://www.mmj.eg.net/text.asp?2018/31/4/1482/252038 |
Body
I read with interest the study by Qora et al.[1] on the effect of irritable bowel syndrome (IBS) on health-related quality of life (QOL) in Qaliobeya Governorate, Egypt. The authors found that QOL was affected by the sex of patients, age less than 30 years, being underweight, number of IBS attacks, and associated symptoms like dyspepsia, stomach pain, and flatulence[1]. I presume that these results ought to be interpreted cautiously. This is based on the presence of the following methodological limitation related to IBS-QOL tool employed in the study. The employed IBS-QOL tool in the study is old, as it was set two decades ago[2]. Moreover, a systematic review study showed that the tool demonstrated moderate positive evidence for internal consistency and reliability and that there was conflicting evidence for its underlying structural validity necessitating further elucidation of the factor structure or dimensionality of the IBS-QOL[3]. In 2016, a new IBS-QOL tool has been developed. Evaluation of it showed that it was easily comprehensible and short, and its internal consistency reliability and test-retest reliability were satisfactory, with a Cronbach's α and intraclass correlation coefficient of 0.93 and 0.88, respectively, rendering it feasible for implementation in the clinical field and researches[4]. I presume that employing the new IBS-QOL tool could yield more accurate results.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References | | |
1. | Qora MA, El Kot MM, Salama AA, Abd El Rahman MS. Quality of life in patients with irritable bowel syndrome in Qaliobeya Governorate, Egypt. Menoufia Med J 2018; 31:438–442. |
2. | Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci 1998; 43:400–411. |
3. | Lee J, Lee EH, Moon SH. A systematic review of measurement properties of the instruments measuring health-related quality of life in patients with irritable bowel syndrome. Qual Life Res 2016; 25:2985–2995. |
4. | Lee EH, Kwon O, Hahm KB, Kim W, Kim JI, Cheung DY, et al. Irritable bowel syndrome-specific health-related quality of life instrument: development and psychometric evaluation. Health Qual Life Outcomes 2016; 14:22. |
|